Merck KGaA Financials
| MRK Stock | 137.85 0.35 0.25% |
Merck |
Please note, the imprecision that can be found in Merck KGaA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck KGaA. Check Merck KGaA's Beneish M Score to see the likelihood of Merck KGaA's management manipulating its earnings.
| Foreign Associates | |
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | DE0006599905 |
| Business Address | Frankfurter Strasse 250, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.merckgroup.com |
| Phone | 49 6151 72 0 |
You should never invest in Merck KGaA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Merck Stock, because this is throwing your money away. Analyzing the key information contained in Merck KGaA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Merck KGaA Key Financial Ratios
Merck KGaA's financial ratios allow both analysts and investors to convert raw data from Merck KGaA's financial statements into concise, actionable information that can be used to evaluate the performance of Merck KGaA over time and compare it to other companies across industries.| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Target Price | 209.1 | |||
| Beta | 0.65 | |||
| Z Score | 1.2 |
Merck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Merck KGaA's current stock value. Our valuation model uses many indicators to compare Merck KGaA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck KGaA competition to find correlations between indicators driving Merck KGaA's intrinsic value. More Info.Merck KGaA is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck KGaA is roughly 2.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck KGaA's earnings, one of the primary drivers of an investment's value.Merck KGaA Systematic Risk
Merck KGaA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Merck KGaA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Merck KGaA correlated with the market. If Beta is less than 0 Merck KGaA generally moves in the opposite direction as compared to the market. If Merck KGaA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Merck KGaA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Merck KGaA is generally in the same direction as the market. If Beta > 1 Merck KGaA moves generally in the same direction as, but more than the movement of the benchmark.
Merck KGaA December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Merck KGaA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merck KGaA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merck KGaA based on widely used predictive technical indicators. In general, we focus on analyzing Merck Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merck KGaA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 10.92 | |||
| Value At Risk | (2.09) | |||
| Potential Upside | 2.08 |
Additional Tools for Merck Stock Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.